University of Bath and Qualasept Limited
Lead Participant:
UNIVERSITY OF BATH
Abstract
To develop, validate and implement novel methods for the characterisation of therapeutic antibody-drug conjugates to generate new products with extended shelf-lives.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| UNIVERSITY OF BATH | £220,532 | £ 147,756 |
Participant |
||
| KTN LTD | ||
| THE UNIVERSITY OF BATH |
People |
ORCID iD |